Deutsch English Français

Contact

EP1575901

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...

Extract from the Register of European Patents

EP About this file: EP1575901

EP1575901 - SUBSTITUTED AMIDES [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 16.08.2013 Database last updated on 19.03.2026
Most recent event Tooltip	18.07.2014	Lapse of the patent in a contracting state New state(s): HU	published on 20.08.2014 [2014/34]
Applicant(s)	For all designated states Merck Sharp & Dohme Corp. 126 East Lincoln Avenue Rahway, NJ 07065-0907 / US
	[2012/41]
Former [2012/33]	For all designated states Merck Sharp & Dohme Corp. 126 East Lincoln Avenue Rahway NJ 07065-0907 / US
Former [2012/32]	For all designated states Schering Corporation 126 East Lincoln Avenue Rahway, NJ 07065-0907 / US
Former [2010/10]	For all designated states Merck Sharp & Dohme Corp. 126 East Lincoln Avenue Rahway, NJ 07065 / US
Former [2005/38]	For all designated states Merck & Co., Inc. (a New Jersey corp.) 126 East Lincoln Avenue Rahway, N.J. 07065 / US
Inventor(s)	01 / LIN, Linus, S. 126 East Lincoln Avenue Rahway, NJ 07065-0907 / US
	02 / HAGMANN, William, K. 126 East Lincoln Avenue Rahway, NJ 07065-0907 / US
	03 / KUMAR, Sanjeev 126 East Lincoln Avenue Rahway, NJ 07065-0907 / US
	04 / YIN, Wenji 126 East Lincoln Avenue Rahway, NJ 07065-0907 / US
	05 / DOSS, George 126 East Lincoln Avenue Rahway, NJ 07065-0907 / US
	[2005/38]
Representative(s)	Horgan, James Michael Frederic, et al Merck Sharp & Dohme Corp. 120 Moorgate London, EC2M 6UR / GB
	[N/P]
Former [2012/41]	Horgan, James Michael Frederic, et al Merck & Co., Inc. European Patent Department Merck Sharpe & Dohme Limited Hertford Road Hoddesdon Hertfordshire EN11 9BU / GB
Former [2006/48]	Horgan, James Michael Frederic, et al Merck & Co., Inc. European Patent Department Merck Sharp & Dohme Limited, Hertford Road, Hoddesdon Hertfordshire, EN11 9BU / GB
Former [2005/38]	Horgan, James Michael Frederic, et al Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road Harlow, Essex CM20 2QR / GB
Application number, filing date	03814048.9	15.12.2003
	[2005/38]
	WO2003US40040
Priority number, date	US20020435436P	19.12.2002 Original published format: US 435436 P
	[2005/38]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2004058145
	Date:	15.07.2004
	Language:	EN
	[2004/29]
	Type:	A2 Application without search report
	No.:	EP1575901
	Date:	21.09.2005
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 15.07.2004 takes the place of the publication of the European patent application.
	[2005/38]
	Type:	B1 Patent specification
	No.:	EP1575901
	Date:	10.10.2012
	Language:	EN
	[2012/41]
Search report(s)	International search report - published on:	US	02.09.2004
	(Supplementary) European search report - dispatched on:	EP	17.02.2009
Classification	IPC:	C07C233/05, C07D213/02, A61K31/44	[2005/38]
	CPC:	C07D213/64 (EP,KR,US); C07C255/60 (EP,KR,US); A61P1/04 (EP); A61P1/10 (EP); A61P1/16 (EP); A61P11/06 (EP); (+) A61P17/02 (EP); A61P25/00 (EP); A61P25/06 (EP); A61P25/08 (EP); A61P25/16 (EP); A61P25/18 (EP); A61P25/20 (EP); A61P25/22 (EP); A61P25/28 (EP); A61P25/30 (EP); A61P3/04 (EP); A61P43/00 (EP); A61P9/10 (EP); C07C275/24 (EP,KR,US); C07C2601/04 (EP,US) (-)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/38]
Extension states	LT	19.07.2005
	LV	19.07.2005
Title	German:	SUBSTITUIERTE AMIDE	[2005/38]
	English:	SUBSTITUTED AMIDES	[2005/38]
	French:	AMIDES SUBSTITUES	[2005/38]
Entry into regional phase	19.07.2005	National basic fee paid
	19.07.2005	Search fee paid
	19.07.2005	Designation fee(s) paid
	19.07.2005	Examination fee paid
Examination procedure	08.07.2004	Request for preliminary examination filed International Preliminary Examining Authority: US
	17.06.2005	Amendment by applicant (claims and/or description)
	19.07.2005	Examination requested [2005/38]
	15.07.2009	Despatch of a communication from the examining division (Time limit: M06)
	11.02.2010	Reply to a communication from the examining division
	30.06.2010	Despatch of a communication from the examining division (Time limit: M02)
	15.07.2010	Reply to a communication from the examining division
	26.08.2010	Despatch of a communication from the examining division (Time limit: M04)
	21.12.2010	Reply to a communication from the examining division
	20.03.2012	Communication of intention to grant the patent
	05.07.2012	Fee for grant paid
	05.07.2012	Fee for publishing/printing paid
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 15.07.2009
Opposition(s)	11.07.2013	No opposition filed within time limit [2013/38]
Request for further processing for:	The application is deemed to be withdrawn due to failure to reply to the examination report
	11.02.2010	Request for further processing filed
	11.02.2010	Full payment received (date of receipt of payment)
Fees paid	Renewal fee
	05.12.2005	Renewal fee patent year 03
	05.12.2006	Renewal fee patent year 04
	05.12.2007	Renewal fee patent year 05
	27.03.2008	Renewal fee patent year 06
	07.12.2009	Renewal fee patent year 07
	22.11.2010	Renewal fee patent year 08
	06.12.2011	Renewal fee patent year 09
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	HU	15.12.2003
	AT	10.10.2012
	BE	10.10.2012
	CY	10.10.2012
	CZ	10.10.2012
	DK	10.10.2012
	EE	10.10.2012
	FI	10.10.2012
	IT	10.10.2012
	RO	10.10.2012
	SE	10.10.2012
	SI	10.10.2012
	SK	10.10.2012
	TR	10.10.2012
	IE	15.12.2012
	LU	15.12.2012
	MC	31.12.2012
	BG	10.01.2013
	GR	11.01.2013
	ES	21.01.2013
	PT	11.02.2013
	[2014/34]
Former [2014/27]	AT	10.10.2012
	BE	10.10.2012
	CY	10.10.2012
	CZ	10.10.2012
	DK	10.10.2012
	EE	10.10.2012
	FI	10.10.2012
	IT	10.10.2012
	RO	10.10.2012
	SE	10.10.2012
	SI	10.10.2012
	SK	10.10.2012
	TR	10.10.2012
	IE	15.12.2012
	LU	15.12.2012
	MC	31.12.2012
	BG	10.01.2013
	GR	11.01.2013
	ES	21.01.2013
	PT	11.02.2013
Former [2014/21]	AT	10.10.2012
	BE	10.10.2012
	CY	10.10.2012
	CZ	10.10.2012
	DK	10.10.2012
	EE	10.10.2012
	FI	10.10.2012
	IT	10.10.2012
	RO	10.10.2012
	SE	10.10.2012
	SI	10.10.2012
	SK	10.10.2012
	TR	10.10.2012
	IE	15.12.2012
	MC	31.12.2012
	BG	10.01.2013
	GR	11.01.2013
	ES	21.01.2013
	PT	11.02.2013
Former [2013/47]	AT	10.10.2012
	BE	10.10.2012
	CY	10.10.2012
	CZ	10.10.2012
	DK	10.10.2012
	EE	10.10.2012
	FI	10.10.2012
	IT	10.10.2012
	RO	10.10.2012
	SE	10.10.2012
	SI	10.10.2012
	SK	10.10.2012
	IE	15.12.2012
	MC	31.12.2012
	BG	10.01.2013
	GR	11.01.2013
	ES	21.01.2013
	PT	11.02.2013
Former [2013/37]	AT	10.10.2012
	BE	10.10.2012
	CY	10.10.2012
	CZ	10.10.2012
	DK	10.10.2012
	EE	10.10.2012
	FI	10.10.2012
	IT	10.10.2012
	RO	10.10.2012
	SE	10.10.2012
	SI	10.10.2012
	SK	10.10.2012
	MC	31.12.2012
	BG	10.01.2013
	GR	11.01.2013
	ES	21.01.2013
	PT	11.02.2013
Former [2013/35]	AT	10.10.2012
	BE	10.10.2012
	CY	10.10.2012
	CZ	10.10.2012
	DK	10.10.2012
	EE	10.10.2012
	FI	10.10.2012
	SE	10.10.2012
	SI	10.10.2012
	SK	10.10.2012
	MC	31.12.2012
	BG	10.01.2013
	GR	11.01.2013
	ES	21.01.2013
	PT	11.02.2013
Former [2013/34]	AT	10.10.2012
	BE	10.10.2012
	CY	10.10.2012
	DK	10.10.2012
	FI	10.10.2012
	SE	10.10.2012
	SI	10.10.2012
	MC	31.12.2012
	BG	10.01.2013
	GR	11.01.2013
	ES	21.01.2013
	PT	11.02.2013
Former [2013/33]	AT	10.10.2012
	BE	10.10.2012
	CY	10.10.2012
	FI	10.10.2012
	SE	10.10.2012
	SI	10.10.2012
	MC	31.12.2012
	GR	11.01.2013
	ES	21.01.2013
	PT	11.02.2013
Former [2013/31]	AT	10.10.2012
	BE	10.10.2012
	CY	10.10.2012
	FI	10.10.2012
	SE	10.10.2012
	SI	10.10.2012
	GR	11.01.2013
	ES	21.01.2013
	PT	11.02.2013
Former [2013/28]	BE	10.10.2012
	CY	10.10.2012
	FI	10.10.2012
	SE	10.10.2012
	SI	10.10.2012
	GR	11.01.2013
	ES	21.01.2013
	PT	11.02.2013
Former [2013/24]	BE	10.10.2012
	CY	10.10.2012
	FI	10.10.2012
	SE	10.10.2012
	SI	10.10.2012
	GR	11.01.2013
	ES	21.01.2013
Former [2013/23]	CY	10.10.2012
	FI	10.10.2012
	SE	10.10.2012
	SI	10.10.2012
	ES	21.01.2013
Former [2013/22]	FI	10.10.2012
	SE	10.10.2012
	SI	10.10.2012
	ES	21.01.2013
Former [2013/21]	SE	10.10.2012
	SI	10.10.2012
Former [2013/11]	SI	10.10.2012
Documents cited:	Search	[PX] WO03082190 (MERCK & CO INC et al.)
		[PX] WO03087037 (MERCK & CO INC et al.)
		[PX] DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; HAGMANN, WILLIAM K. ET AL: "Preparation of spirocyclic carboxamides as cannabinoid receptor modulators", XP002513691, retrieved from STN Database accession no. 2003:796415 [PX] 1-11 * abstract *
		[PX] DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; HAGMANN, WILLIAM K. ET AL: "Preparation of substituted arylamides as cannabinoid-1 receptor antagonists and/or inverse agonists for use as psychotropic drugs", XP002513692, retrieved from STN Database accession no. 2003:837028 [PX] 1-11 * abstract *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.3.42; 40p